Apotex's Claim Of Provigil Monopoly To Be Decided At Trial
A Pennsylvania federal judge on Tuesday refused to grant Apotex Inc. summary judgment that Cephalon Inc. had monopoly power over the market for modafinil, the active ingredient in the narcolepsy drug...To view the full article, register now.
Already a subscriber? Click here to view full article